Novel Coronavirus (SARS-CoV-2/COVID-19)
Hospitals’ already thin margins plunged into the red in March as non-emergency procedures and revenues fell and expenses for staff, supplies and building capacity rose to prepare for a surge in COVID-19 patients, according to a new report by health care consultancy Kaufman Hall.
The Food and Drug Administration authorized the first diagnostic test with a home collection option for COVID-19.
A panel of experts convened by the National Institutes of Health released COVID-19 treatment guidelines for health care providers, which will be updated as new data become available.
The FBI warned today of specific COVID-19-themed email phishing campaigns targeting U.S.-based medical providers.
The Food and Drug Administration said that it will temporarily forgo action against 503A compounding pharmacies that provide to hospitals certain compounded drugs without patient-specific prescriptions.
AHA statement on the Paycheck Protection Program & Health Care Enhancement Act from President and CEO Rick Pollack.
Following a global increase in malicious cyber activity exploiting fear derived from the COVID-19 pandemic, the FBI was notified of targeted email phishing attempts against US-based medical providers.
The AHA urged the Department of Health and Human Services and the Health Resources and Services Administration to provide flexibility in the administration of the 340B Drug Pricing Program to better enable these hospitals to serve their communities during the COVID-19 national emergency.
The Centers for Medicare & Medicaid Services April 21 and April 23 will host calls for hospitals, health systems and providers on COVID-19.
When the World Health Assembly designated 2020 as the International Year of the Nurse and the Midwife, they had no idea a pandemic would envelop the world the same year. The convergence of these events is a poignant reminder of nurses’ vital role in caring for patients, comforting families and…